46 results
8-K
EX-10.1
fjnb05fad45
28 Mar 24
Entry into a Material Definitive Agreement
7:55am
8-K
f4oqhzvebn8xdsy
19 Jan 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
EX-99.1
vn8b29r9gsn0wgb
5 Sep 23
Xilio Therapeutics Announces Promotion of Katarina Luptakova, M.D., to Chief Medical Officer and Scott Coleman, Ph.D., to Chief Development Officer
8:35am